Jeani Delagardelle

Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners.

Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA

Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA.

Aspire Medical is a privately held, venture capital financed medical device company developing minimally invasive surgical treatments for obstructive sleep apnea (OSA). The procedure is conducted by ear, nose, and throat (ENT) specialists, who are also known as otolaryngologists. The company was founded in 2004.

Spiration, Inc. developed, manufactured and marketed medical devices for the treatment of air leaks and lung disease. The company was founded in 1999 and was headquartered in Redmond, WA.

Radiant Medical, Inc. develops and manufactures endovascular temperature therapy products. Its products are used for the treatment of radiocontrast nephropathy, heart attack, and cardiac arrest. The company was founded in 1997 and is located in Redwood City, CA.

Part of CMIC Holdings Co., Ltd., Cell Product, Inc. is a Japanese company that provides services in Site Management Organization (SMO). The company is based in Sapporo, Japan. Cell Product was acquired by SSI-CP Co., Ltd. on January 05, 2006.

New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group.

Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ.

CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA.

Spiracur, Inc. develops innovative wound healing technologies. Its products include smart negative pressure wound care system that includes cartridge, hydrocolloid dressing, and interface layer for the treatment of chronic and acute wounds; and ciSNaP closed incision systems, including sterile cartridges, controlled tension relief layers, advanced surgical dressing, and straps for patients undergoing high-risk procedures, including orthopedic, abdominal, vascular, and podiatric surgeries. The company was founded by Kenton D. Fong and Moshe Pinto in 2007 and is headquartered in Sunnyvale, CA.

Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.

Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong.